© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Prevention
How Well Do U=U and PrEP Work? The CDC Updates Its Answers
#PrEP
#Cure

1 in 9 Gay and Bi Men With HIV Report Sex That Poses Transmission Risk

This is according to nationally representative survey data of gay and bi men diagnosed with the virus.
Christopher Kahler, PhD, chair of behavioral and social sciences at Brown University

What’s the Best Way to Address the Alcohol Misuse That Fuels HIV?

With the help of a $6.2 million grant, researchers at Brown University hope to find out.

Concerns Arise Over Blood Donated by People on Antiretrovirals

Whether the donor uses antiretrovirals for HIV treatment or as PrEP, the drugs could mask the presence of the virus in a blood donation.

AVAC Launches Dynamic Global PrEP Data Tool

The HIV advocacy group has been assiduously tracking PrEP data for five years.

$109M to End HIV in America

The CDC funding goes to 32 state and local health departments as part of a federal initiative.

Treatment as Prevention (TasP)

MUST read

Safer Sex
drug users passing a syringe
Safer Injecting
Treatment-as-Prevention (TasP)

HIV Prevention

Model of the VRC01 Antibody

Partnership Launches to Develop and Test HIV Antibody Combinations

Products based on broadly neutralizing antibodies could be used in HIV treatment and prevention.

House Budgeting Bill Increases Funding to HIV and Health Care

The bill includes support for HIV research, the Ryan White HIV/AIDS programs and more. A date for the full House review has not been set.

New Way to Prevent HIV and Substance Misuse Among Minority Youth?

A federal grant for a Latino adolescent center in the South Bronx will help evaluate a new peer-based approach.

STI Rate Did Not Rise During Descovy Versus Truvada PrEP Trial

The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.

PrEP Cuts HIV Rate by Three Quarters in African Study

The SEARCH study included men and women at elevated risk of HIV in Kenya and Uganda.

COVID-19 Threatens LGBT People’s Economic Security

The new global pandemic could also lead to greater susceptibility to HIV transmission.

Injectable PrEP Is Even More Effective Than Daily Truvada

The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.

Global HIV Treatment Rates Rise, but Progress Is Uneven

Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.

Prevention: Long-Acting PrEP

The injectable cabotegravir, given every eight weeks, is just as effective as daily Truvada for HIV prevention.
Advertisement
Features
Opinions